Table 5. Changes in CK2 gene expression in ovarian cancer.

Gene	P-Value	Fold Change	Rank (Top %)	DataSet	#Samples	Reference
Ovarian Serous Adenocarcinoma
CK2α	4.22 10−11	2.3	1%	Yoshihara	53	[77]
CK2α'	7.44 10−6	−1.2	1%	Lu Ovarian	50	[78]
	0.005	−1.4	6%	Adib	16	[79]
CK2β	4.75 10−8	1.7	3%	Yoshihara	53	[77]
Ovarian Carcinoma
CK2α	1.23 10−11	1.7	3%	Bonome	195	[80]
CK2β	1.39 10−5	1.4	19%	Bonome	195	[80]
Ovarian Serous Cystadenocarcinoma
CK2α	6.51 10−6	1.7	7%	TCGA Ovarian	594	[68]
Ovarian Endometroid Adenocarcinoma
CK2β	0.01	1.6	11%	Lu Ovarian	50	[78]
Ovarian Mucinous Adenocarcinoma
CK2α'	1.82 10−4	−1.2	1%	Lu Ovarian	50	[78]

Different subtypes of ovarian cancer are analyzed and p-values, fold changes, and datasets are included.